Sprague–Dawley Rat Primary Hepatocytes

Sprague–Dawley Rat Primary Hepatocytes

Catalog No. RA-6224F

Suggested Medium: Hepatocyte Medium /w Kit (500 ml)

Catalog No. M1265

Product Description

Rat Primary Hepatocytes are derived from the liver of laboratory Sprague–Dawley rat. Cells are freshly isolated and frozen at passage 0. Each vial contains 3 x10⁶ cells. Cells are negative for bacteria, yeast, fungi, and mycoplasma. Rat Primary Hepatocytes are tested for expression of markers using antibodies, ZO-1 by Immunofluorescence Staining. Cells can be expanded on multiwell culture plates ready for experiments under the cell culture conditions specified by Cell Biologics. The plateable cells are derived from pooled or single donor. Viabilities generally >75%.

Laboratory Applications

Rat Primary Hepatocytes can be used in standard biochemical procedures include PCR, Western blotting, immunoprecipitation, metabolism, drug-drug interaction, drug transporter activity toxicity of drug candidates or cell derivatives for desired research applications.

Authorized Uses of Cell Biologics’ Products

Rat Primary Hepatocytes from Cell Biologics are distributed for internal research purposes only. Our products are not authorized for human use, for in vitro diagnostic procedures or for therapeutic procedures. Transfer or resale of any Cell Biologics’ cells or products from the purchaser to other markets, organizations or individuals is prohibited by Cell Biologics, without the company’s written consent. Cell Biologics’ Terms and Conditions must be accepted before submitting an order.

Disclaimer

Investigators should handle the cells that they receive from Cell Biologics with caution and treat all animal cells as potential pathogens, since no test procedure can completely guarantee the absence of infectious agents.

Warranty and Liability

Cell Biologics’ guarantee applies only to your purchase of Cell Biologics’ cells with Cell Biologics’ Media and Coating Solution for appropriate cell culture and cell testing following Cell Biologics’ online protocols within 35 days from the date of product delivery.